Novocure
NVCR
#5392
Rank
C$1.87 B
Marketcap
Country
C$16.73
Share price
2.98%
Change (1 day)
-55.14%
Change (1 year)
Categories

Revenue for Novocure (NVCR)

Revenue in 2025 (TTM): C$0.90 Billion

According to Novocure 's latest financial reports the company's current revenue (TTM ) is C$0.88 Billion. In 2024 the company made a revenue of C$0.86 Billion an increase over the revenue in the year 2023 that were of C$0.67 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Novocure from 2015 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) C$0.90 B4.01%
2024 C$0.86 B28.56%
2023 C$0.67 B-7.43%
2022 C$0.72 B7.03%
2021 C$0.68 B8.17%
2020 C$0.63 B37.38%
2019 C$0.45 B35.78%
2018 C$0.33 B51.83%
2017 C$0.22 B99.81%
2016 C$0.11 B142.69%
2015 C$45.89 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novocure
NVCR
C$0.88 B 0.00% Jersey
Novavax
NVAX
C$1.41 B 59.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
C$0.19 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
C$30.17 M-96.60%๐Ÿ‡ฌ๐Ÿ‡ง UK